Erratum to “To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound” [European Journal of Cancer, 42 (2006) 2472–2479]

✍ Scribed by Michele Lamuraglia; Bernard Escudier; Linda Chami; Brian Schwartz; Jérome Leclère; Alain Roche; Nathalie Lassau

• Book ID: 116429040
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 91 KB
• Volume: 43
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2006.04.034